Reforming EU and national orphan drug regulations to improve outcomes for patients with rare diseases

May 9, 2023

9

Philip Kranz researcher, Natalie McGauran researcher, Rita Banzi researcher, Can Ünal researcher, Fabian Lotz researcher, Thomas Kaiser director et al

Kranz P, McGauran N, Banzi R, Ãnal C, Lotz F, Kaiser T et al.

Reforming EU and national orphan drug regulations to improve outcomes for patients with rare diseases

BMJ 2023; 381 :e072796

doi:10.1136/bmj-2022-072796

Source link

Reforming EU and national orphan drug regulations to improve outcomes for patients with rare diseases

Like this:

Related Articles

ACNAP 2023 highlights the artistic and scientific dimensions of cardiovascular care

Weight loss surgeries on the rise among kids and teens, study finds: ‘Altering the anatomy’

Mark Cuban calls Yusimry’s availability on MCCPDC ‘a game changer’

Leave a Reply Cancel reply

Latest Articles

ACNAP 2023 highlights the artistic and scientific dimensions of cardiovascular care

Weight loss surgeries on the rise among kids and teens, study finds: ‘Altering the anatomy’

Mark Cuban calls Yusimry’s availability on MCCPDC ‘a game changer’

At ASCO, BioNTech Shows Encouraging Data for Drug That Led to $200M Deal – MedCity News

Children with drug-resistant epilepsy live longer after cranial surgery, large study finds

Reforming EU and national orphan drug regulations to improve outcomes for patients with rare diseases

Share this:

Like this:

Related Articles

Leave a Reply Cancel reply

Stay Connected

Latest Articles